Goldman Sachs Downgrades Medivation To Neutral, Shares Drop

Analysts at Goldman Sachs downgraded Medivation

from Buy to Neutral. The target price for Medivation has been raised from $90 to $110. Medivation shares have jumped 70.25% over the past 52 weeks, while the S&P 500 index has surged 17.13% in the same period. Medivation's shares fell 2.11% to $96.51 in pre-market trading.